INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE)

CUSIP: 46137V787

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / BIOTECHNOLOGY
Total 13F shares
1,073,571
Share change
+95,931
Total reported value
$88,201,149
Price per share
$82.15
Number of holders
109
Value change
+$7,979,067
Number of buys
44
Number of sells
34

Quarterly Holders Quick Answers

What is CUSIP 46137V787?
CUSIP 46137V787 identifies PBE - INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of PBE - INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) as of Q4 2025

As of 31 Dec 2025, INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) was held by 109 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,073,571 shares. The largest 10 holders included MORGAN STANLEY, UNITED CAPITAL FINANCIAL ADVISORS, LLC, LPL Financial LLC, UBS Group AG, BANK OF AMERICA CORP /DE/, ROYAL BANK OF CANADA, WELLS FARGO & COMPANY/MN, Gerber Kawasaki Wealth & Investment Management, YHB Investment Advisors, Inc., and Cetera Investment Advisers. This page lists 109 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
98
Q4 2025 holders
109
Holder diff
11
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .